FFA
AQST icon

Farther Finance Advisors’s Aquestive Therapeutics AQST Stock Holding History

Farther Finance Advisors’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56 Buy
12
+11
+1,100% +$49 ﹤0.01% 6017
2026
Q2 		$4 Hold
1
– – ﹤0.01% 5948
2026
Q1 		$4 Buy
+1
New +$4 ﹤0.01% 5713

Other funds holding AQST

ACA
Adirondack Capital Advisors Syracuse, New York $194M AUM 14.02% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's AQST Position: Q3 2026 in Review

Farther Finance Advisors increased its Aquestive Therapeutics (AQST) stake by 1,100% in Q3 2026, buying an estimated $49 and bringing the position to 12 shares worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #6017.

Farther Finance Advisors first reported a position in AQST in Q1 2026 and has held it in 3 quarters since. 5 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Farther Finance Advisors held 12 shares of Aquestive Therapeutics worth $56 as of Q3 2026.
  • Farther Finance Advisors bought 11 Aquestive Therapeutics shares in Q3 2026, an estimated $49.
  • Aquestive Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6017 holding.
  • Farther Finance Advisors first reported a position in Aquestive Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 5 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.